Programme subject to change. All session times are listed in Europe/Rome Time Zone (CET) (UTC+1).
-
Thursday, Nov 12th
11:15 - 12:45 CETInstructional Course: High-Quality TURBT - Practical Strategies to Improve OutcomesCo-Chair: – Clínica Alemana Universidad del Desarrollo
Co-Chair: – University of Texas MD Anderson Cancer Center
-
Thursday, Nov 12th
11:15 - 11:20 CETWelcome and IntroductionSpeaker: – Clínica Alemana Universidad del Desarrollo
Speaker: – University of Texas MD Anderson Cancer Center
-
Thursday, Nov 12th
11:20 - 11:30 CETWhy TURBT Quality Still Matters in 2026 – Impact on NMIBC OutcomesSpeaker: – University of Texas MD Anderson Cancer Center
-
Thursday, Nov 12th
11:30 CETEXPERT TALK I – SURGICAL STANDARDS - WHAT DEFINES A HIGH-QUALITY TURBT? -
Thursday, Nov 12th
11:30 - 11:35 CETPre-Operative Assessment and PlanningSpeaker: – Tata Memorial Hospital, Homi Bhabha National Institute
-
Thursday, Nov 12th
11:35 - 11:40 CETEn bloc vs Conventional TURBT: Evidence-Based IndicationsSpeaker: – The Chinese University of Hong Kong
-
Thursday, Nov 12th
11:40 - 11:45 CETMandatory Detrusor Muscle Sampling In Every Patient?Speaker: – Clínica Alemana Universidad del Desarrollo
-
Thursday, Nov 12th
11:45 - 11:50 CETManaging Large and Multifocal TumorsSpeaker: – University of Texas MD Anderson Cancer Center
-
Thursday, Nov 12th
11:50 CETINTERACTIVE SURGICAL VIDEO PEARLS - TURBT IN PRACTICE: DOING IT RIGHT -
Thursday, Nov 12th
11:50 - 11:58 CETMuscle Identification and Specimen IntegritySpeaker: – The Chinese University of Hong Kong
-
Thursday, Nov 12th
11:58 - 12:06 CETCommon Technical Pitfalls – Obturator Reflex, Bladder Wall Perforation, Resection Of Ureteral Orifice And Massive Intraoperative BleedingSpeaker: – Universidad Veracruzana
-
Thursday, Nov 12th
12:06 - 12:14 CETReducing Thermal Artifact and Incomplete ResectionSpeaker: – Tata Memorial Hospital, Homi Bhabha National Institute
-
Thursday, Nov 12th
12:15 CETEXPERT TALK II – BEYOND THE RESECTION - TURBT QUALITY AND CLINICAL DECISION-MAKING -
Thursday, Nov 12th
12:15 - 12:20 CETWhen and Why to Perform Re-TURBTSpeaker: – Universidad Veracruzana
-
Thursday, Nov 12th
12:20 - 12:25 CETImmediate Intravesical Therapy: Patient SelectionSpeaker: – Clínica Alemana Universidad del Desarrollo
-
Thursday, Nov 12th
12:25 - 12:45 CETDISCUSSION AND TAKE-HOME MESSAGES: What To Change Tomorrow in Your OR – Key Messages For Daily PracticeModerator: – Clínica Alemana Universidad del Desarrollo
Moderator: – University of Texas MD Anderson Cancer Center
Panelist: – Tata Memorial Hospital, Homi Bhabha National Institute
Panelist: – The Chinese University of Hong Kong
Panelist: – Universidad Veracruzana
-
Thursday, Nov 12th
14:00 - 15:30 CETHot Topic: Bladder Cancer: New Agents in the Setting of Unequal Access Across the WorldCo-Chair: – Clínica Alemana Universidad del Desarrollo
Co-Chair: – University of Texas Medical Branch, USA, Texas
-
Thursday, Nov 12th
14:00 - 14:15 CETRapidly Evolving Treatment Landscape in BC. What Are the Reasonable Thresholds for a Drug to Become the New Standard?Speaker: – University of Chicago
-
Thursday, Nov 12th
14:15 - 14:30 CETClinical and Logistical Challenges of Perioperative Systemic Therapy for MIBC in Emerging RegionsSpeaker: – Hassan II University Hospital
-
Thursday, Nov 12th
14:30 CETPanel 1. Global Practice Variation in NMIBC -
Thursday, Nov 12th
14:30 - 14:38 CETWhat Is the Real Need for New Agents If BCG Treatment Is Adequate?Speaker: – Clínica Alemana Universidad del Desarrollo
-
Thursday, Nov 12th
14:38 - 14:46 CETGeneric Agents as More Accessible Alternatives in Emerging RegionsSpeaker: – Aga Khan University
-
Thursday, Nov 12th
14:46 - 14:54 CETNew Drugs for NMIBC – Will They Be Cost Efficient?Speaker: – University of Texas Medical Branch, USA, Texas
-
Thursday, Nov 12th
14:54 - 15:04 CET -
Thursday, Nov 12th
15:04 CETPanel 2. Radical Cystectomy – Still the way to go in BCG-unresponsive NMBIC? -
Thursday, Nov 12th
15:04 - 15:12 CETEarly Cystectomy: A Value‑Driven Approach to Managing BCG‑Unresponsive NMIBC -
Thursday, Nov 12th
15:12 - 15:20 CETEarly Cystectomy Optimizes Cancer Control and Quality of LifeSpeaker: – University of British Columbia
-
Thursday, Nov 12th
15:20 - 15:30 CET -
Thursday, Nov 12th
16:00 - 17:30 CETInstructional Course: Saving the Bladder in Muscle-invasive Bladder Cancer: Multidisciplinary Tips and Tricks -
Saturday, Nov 14th
11:15 - 12:45 CETMaster Class: Bladder Cancer: Bladder Preservation & Precision ManagementCo-Chair: – Fox Chase Cancer Center
Co-Chair:
Co-Chair: – University of British Columbia
-
Saturday, Nov 14th
11:15 CETThe cT0 Conundrum & Evolving Standards -
Saturday, Nov 14th
11:15 - 11:20 CETDoes cT0 = pT0?Speaker: – Fox Chase Cancer Center
-
Saturday, Nov 14th
11:20 - 11:30 CETPrecision Clinical Staging (Starburst-1) -
Saturday, Nov 14th
11:30 CETDebate: For a patient with persistent cT0 after neoadjuvant therapy, radical cystectomy is overtreatment -
Saturday, Nov 14th
11:30 - 11:37 CET -
Saturday, Nov 14th
11:37 - 11:44 CET -
Saturday, Nov 14th
11:45 - 12:00 CETNeoadjuvant TherapySpeaker: – The Royal Marsden Foundation Trust
-
Saturday, Nov 14th
12:00 - 12:15 CETAiming for Cure, Sparing the Bladder: The Art of Precision Radiotherapy -
Saturday, Nov 14th
12:15 - 12:25 CETNew clinical trials: NeoBlastSpeaker: – University of British Columbia
-
Saturday, Nov 14th
12:25 - 12:45 CETPanel Discussion/Q & AModerator:
Panelist: – Fox Chase Cancer Center
Panelist:
Panelist:
Panelist:
Panelist: – The Royal Marsden Foundation Trust
Panelist: – University of British Columbia
-
Saturday, Nov 14th
14:00 - 15:30 CETControversies in Urology: Locally Advanced Bladder Cancer - Multidisciplinary Management After Systemic Therapy ResponseCo-Chair: – Aga Khan University
Co-Chair: – Rajiv Gandhi Cancer Institute & Research Centre
-
Saturday, Nov 14th
14:00 - 14:08 CETEvolving Standards of Systemic Therapy in Locally Advanced and Metastatic Bladder Cancer Based on Global Access -
Saturday, Nov 14th
14:08 - 14:16 CETImaging and staging of node-positive and M1a bladder cancer: CT vs PET and response assessment pitfalls -
Saturday, Nov 14th
14:16 CETWHAT NEXT AFTER COMPLETE RESPONSE TO SYSTEMIC THERAPY IN N+/M1 DISEASE -
Saturday, Nov 14th
14:17 - 14:20 CETDEBATE: N1/2 Disease After Response to Systemic Therapy - Post-response Local Management in N1/N2 Disease (Introduction)Speaker: – Aga Khan University
-
Saturday, Nov 14th
14:20 - 14:25 CETMaking a Case for Active Surveillance After Response in N1/2 Disease -
Saturday, Nov 14th
14:25 - 14:30 CETMaking a Case for Surgery After Response in N1/2 Disease -
Saturday, Nov 14th
14:30 - 14:35 CETMaking a Case for Bladder Preservation After Response in N1/2 Disease -
Saturday, Nov 14th
14:35 - 14:39 CETN3 and M1a Disease After Response to Systemic Therapy (Introduction) -
Saturday, Nov 14th
14:39 - 14:47 CETLocal consolidative approaches in N3 and oligometastatic M1a disease -
Saturday, Nov 14th
14:47 - 14:55 CETWould RC Ever Be an Option and Why? -
Saturday, Nov 14th
14:55 - 15:03 CETPrecision and Risk-adapted Management in Metastatic UC - Treatment Breaks, Surveillance and Intensification Strategies Using Ctdna/mrd After Major Response -
Saturday, Nov 14th
15:03 - 15:30 CETCase-based Panel - N2 MIBC, Not Responding to Therapy
